Substituted oxazolidinone derivatives

Details Substituted oxazolidinone derivatives Substituted oxazolidinone derivatives

2011-07-26

2011-07-26

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S137000

Reexamination Certificate

active

07985750

ABSTRACT:
This invention relates to novel compounds that are substituted oxazolidinones derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel oxazolidinones compounds that are derivatives of rivaroxaban. The invention also provides pyrogen-free compositions comprising one or more compounds of the invention and a carrier, and the use of the disclosed compounds and compositions in methods of treating diseases and condition that are beneficially treated by administering a selective inhibitor of factor Xa, such as rivaroxaban.

REFERENCES:
patent: 6221335 (2001-04-01), Foster
patent: 6440710 (2002-08-01), Keinan et al.
patent: 6603008 (2003-08-01), Ando et al.
patent: 7517990 (2009-04-01), Ito et al.
patent: 2004/0242660 (2004-12-01), Straub et al.
patent: 2007/0082929 (2007-04-01), Gant et al.
patent: 2007/0197695 (2007-08-01), Potyen et al.
patent: 2008/0103122 (2008-05-01), Veltri
patent: 2009/0076264 (2009-03-01), Czarnik
patent: 10 2004 062 475 (2006-07-01), None
patent: 10 2005 047 564 (2007-05-01), None
patent: 1 479 675 (2004-11-01), None
patent: WO 95/26325 (1995-10-01), None
patent: WO 2007/118651 (2007-10-01), None
Roehrig et al., J. Med. Chem., 2005, 48, 5900-5908.
Baillie, Pharmacology Rev.1981; 33: 81-132.
PCT International Search Report for International Application No. PCT/US2008/009704, Date of Mailing: Dec. 23, 2008.
PCT Written Opinion of the International Searching Authority for International Application No. PCT/US2008/009704, Date of Mailing: Dec. 23, 2008.
Fisher, M.B. et al., “The Complexities Inherent in Attempts to Decrease Drug Clearance by Blocking Sites of CYP-Mediated Metabolism,”Curr. Opin. Drug Discov., 9(1): 101-109 (Jan. 2006).
Kushner, D.J. et al., “Pharmacological Uses and Perspectives of Heavy Water and Deuterated Compounds,”Can. J. Physiol. Pharmacol., 77(2): 79-88 (Feb. 1999).
Weinz, C. et al., “195. In Vitro Metabolism of Bay 59-7939—An Oral, Direct Factor Xa Inhibitor” and “196. Metabolism and Distribution of [14C]Bay 59-7939—An Oral, Direct Factor Xa Inhibitor—In Rat, Dog and Human,”Drug Metabolism Reviews, vol. 36, Issue Suppl. 1, p. 98 (Dec. 2004).
Baillie, Thomas A., “The Use of Stable Isotopes in Pharmacological Research”,Pharmacological Reviews, vol. 33, No. 2, pp. 81-132, 1981.
Browne, Thomas R., “Stable Isotope Techniques in Early Drug Development: An Economic Evaluation”,J. Clin. Pharmacol, vol. 38, pp. 213-220, 1998.
Cherrah, et al., “Study of Deuterium Isotope Effects on Protein Binding by Gas Chromatography/Mass Spectrometry, Caffeine and Deuterated Isotopomers”,Biomedical and Environmental Mass Spectrometry, vol. 14, pp. 653-657, 1987.
Dyck, et al., “Effects of Deuterium Substitution on the Catabolism of β-Phenylethylamine: An In Vivo Study”,Journal of Neurochemistry, vol. 46, No. 2, pp. 399-404, 1986.
Foster, Allan B., “Deuterium isotope effects in studies of drug metabolism”,TIPS, pp. 524-527, 1984.
Foster, Allan B., “Deuterium Isotope Effects in the Metabolism of Drugs and Xenobiotics: Implications for Drug Design”,Advances in Drug Research, vol. 14, pp. 1-40, 1985.
Gouyette, et al., “Synthesis of Deuterium-labelled Elliptinium and its Use in Metabolic Studies”,Biomedical and Environmental Mass Spectrometry, vol. 15, pp. 243-247, 1988.
Haskins, N.J., “The Application of Stable Isotopes in Biomedical Research”,Biomedical Mass Spectrometry, vol. 9, No. 7, pp. 269-277, 1982.
Honma, et al., “Liberation of Deuterium from the Piperidine Ring during Hydroxylation”,Drug Metabolism and Disposition, vol. 15, No. 4, pp. 551-559, 1987.
Pieniaszek, et al., “Moricizine Bioavailablity via Simultaneous, Dual, Stable Isotope Administration: Bioequivalence implications”,The Journal of Clinical Pharmacology, vol. 39, pp. 817-825, 1999.
Tonn, et al., “Simultaneous Analysis of Diphenhydramine and a Stable Isotope Analog (2H10)Diphenhydramine Using Capillary Gas Chromatography with Mass Selective Detection in Biological Fluids from Chronically Instrumented Pregnant Ewes”,Biological Mass Spectrometry, vol. 22, pp. 633-642, 1993.
Wolen, Robert L., “The Application of Stable Isotopes to Studies of Drug Bioabailablity and Bioequivalence”,The Journal of Clinical Pharmacology, vol. 26, pp. 419-424, 1986.

Affiliated with

Also associated with

Rating

Substituted oxazolidinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted oxazolidinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted oxazolidinone derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2736128